When should a patient with acute pyelonephritis be admitted to the hospital?

When to Admit Pyelonephritis

Admit patients with acute pyelonephritis who require intravenous antibiotics due to severe illness, inability to tolerate oral therapy, or presence of complicating factors that increase risk of treatment failure or mortality.

Clinical Decision Framework

The decision to hospitalize hinges on distinguishing uncomplicated from complicated pyelonephritis and assessing illness severity at presentation 1, 2.

Patients Who Should Be Admitted

Admit patients with any of the following:

• Severe systemic illness: Sepsis, severe sepsis, or septic shock (28% of complicated pyelonephritis patients present with severe sepsis/septic shock) 3
• Inability to maintain oral hydration or take oral medications due to nausea, vomiting, or altered mental status
• Complicated pyelonephritis requiring parenteral therapy and possible intervention 1, 2
• High-risk clinical features predicting mortality or treatment failure 4

Risk Stratification for Mortality

A validated scoring system identifies patients at highest risk 4:

For Men:

• Shock: 6 points
• Bedridden status: 4 points
• Age >65 years: 4 points
• Previous antibiotic treatment: 3 points

For Women:

• Shock: 6 points
• Bedridden status: 4 points
• Age >65 years: 4 points
• Immunosuppression: 3 points

Patients scoring ≥11 points have 91-100% mortality risk and require immediate hospitalization 4.

Additional Risk Factors for Severe Sepsis/Septic Shock

These factors independently predict severe sepsis and warrant strong consideration for admission 3:

• Age >65 years
• Recent urinary instrumentation (within 2 weeks)
• Absence of typical symptoms (lack of mictional syndrome or costovertebral tenderness—paradoxically indicates more severe disease)
• Urinary tract ectasia ≥grade II
• Bacteremia

Factors Predicting Treatment Failure or Resistant Pathogens

Admit patients with these characteristics, as they predict resistant organisms 4:

• Recent hospitalization
• Previous antibiotic use
• Immunosuppression
• Nephrolithiasis (in women)
• Recurrent pyelonephritis (in men)
• Diabetes with long-term catheterization

Patients Who Can Be Managed Outpatient

Patients with mild to moderate uncomplicated pyelonephritis can be treated outpatient if they:

• Can tolerate oral medications and maintain hydration
• Have reliable follow-up
• Lack high-risk features listed above
• Have no evidence of urinary obstruction or structural abnormalities
• Are not pregnant
• Have no significant immunosuppression beyond diabetes alone

The guidelines explicitly state that oral fluoroquinolones are "appropriate for therapy in patients not requiring hospitalization" 1. This implies the converse: patients requiring hospitalization need intravenous therapy initially 1.

Important Clinical Nuances

Age and Diabetes Alone Are Not Admission Criteria

A critical pitfall: Many clinicians reflexively admit all elderly or diabetic women with pyelonephritis. However, age and diabetes alone are NOT independently associated with need for admission when other factors are controlled 5. The decision should be based on illness severity and other risk factors, not age or diabetes in isolation.

Laboratory and Imaging Considerations

While not explicitly admission criteria in the guidelines, these findings should prompt hospitalization:

• Low serum albumin (OR 1.96 for admission) 5
• Elevated C-reactive protein (OR 2.57 for admission) 5
• Abnormal imaging findings (52% of imaged patients have abnormalities; abnormal imaging has OR 4.51 for admission) 6
• Evidence of abscess, nephronia, or hydronephrosis 7, 6

Initial Intravenous Therapy for Hospitalized Patients

Once admitted, initiate broad-spectrum IV antibiotics 1:

• Fluoroquinolone (IV), OR
• Aminoglycoside ± ampicillin, OR
• Extended-spectrum cephalosporin or penicillin ± aminoglycoside, OR
• Carbapenem

Tailor therapy based on local resistance patterns and adjust according to culture results 1.

The 10% Resistance Threshold

The guidelines use a 10% fluoroquinolone resistance threshold to determine outpatient oral therapy appropriateness 1. When local resistance exceeds 10%, even outpatients should receive an initial IV dose of long-acting parenteral antibiotic (ceftriaxone 1g or aminoglycoside) before transitioning to oral therapy. This suggests that in high-resistance areas, brief hospitalization or observation unit management may be warranted even for otherwise uncomplicated cases.